XM does not provide services to residents of the United States of America.

Canopy Growth posts smaller-than-expected core loss as costs drop



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Canopy Growth posts smaller-than-expected core loss as costs drop</title></head><body>

Aug 8 (Reuters) -Canadian pot firm Canopy Growth WEED.TO reported a smaller-than-expected core loss for the first quarter on Friday, helped by lower operating expenses and stronger demand for medical cannabis.

Its U.S.-listed shares CGC.O were up 3.3% at $7.15 in premarket trading.

Faced with increased competition in an overcrowded market, North American pot companies have been cutting costs and taking measures to reduce inventories to preserve cash and improve their finances.

Canopy Growth'squarterly operating expenses fell 23.7% to C$52.1 million ($37.92 million) from a year ago.

Revenue from its Canadian medical cannabis business rose 20.3% to C$18.8 million in the quarter ended June 30.

The company expects to achieve positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) on a consolidated basis in the second half of the fiscal year, CEO David Klein said.

Canopy Growth also pointed to easing doubts around the company's ability to continue as a going concern.

The company had raised doubts about its ability to continue as a going concern last year as it struggled to turn profitable. It later sold its sports nutrition products unit, Biosteel, after seeking bankruptcy protection for it.

The company reported a first-quarter adjusted core loss of C$5.3 million, compared with analysts' average estimate of C$7.1 million, according to LSEG data.

Peer Aurora Cannabis ACB.TO reported strong quarterly results earlier this week, helped by growth in medical cannabis segment.


($1 = 1.3739 Canadian dollars)



Reporting by Tanay Dhumal in Bengaluru; Editing by Shreya Biswas

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.